Hmedium: Frost & Sullivan Released the Global Antibody Drug Industry Development Blue Book 2026

Frost & Sullivan has officially released the "Global Antibody Drug Industry Development Blue Book 2026". The Blue Book provides a systematic overview ...

United Airlines: United Posts Q2 Results Above Wall Street Expectations and Raises Full-Year 2026 Adjusted EPS Guidance Despite a Nearly $6 Billion Increase In Anticipated Fuel ...

Q2 diluted earnings per share were $2.46; Q2 adjusted diluted earnings per share2 were $1.99 Full-year adjusted diluted earnings per share guidance1 raised to $9.00 ...

QVC Group, Inc.: QVC Group Achieves Key Milestone with Court's Approval of Comprehensive Financial Restructuring Plan

Confirmed Plan Provides for Significant Reduction of Debt and Unimpaired Treatment for All Vendors Strengthened Financial Position Will Support Company's Ongoing Advancement ...

The Hanover Insurance Group, Inc.: The Hanover Announces CEO Succession Plan: John C. Roche to Retire as President and CEO at the End of 2026; Chief Operating Officer Richard W ...

The Hanover Insurance Group, Inc., (NYSE: THG), a leading property and casualty insurance company, announced today that John "Jack" C. Roche ...

RxSight, Inc.: RxSight Announces Appointments of Aziz Mottiwala as Chief Executive Officer and Ron Kurtz, M.D. as Chief Medical Officer

RxSight, Inc. (NASDAQ: RXST) today announced a planned leadership transition effective July 20, 2026, with Aziz Mottiwala appointed President and ...

Atlas Copco AB: Chinese heating and cooling equipment manufacturer to become part of Atlas Copco Group

Guangdong Euroklimat Air-Conditioning & Refrigeration Co., Ltd ("Guangdong Euroklimat") a Chinese manufacturer of industrial heating and cooling solutions will become part ...

BayFirst Financial Corp.: BayFirst Announces Impact of Asset Resolution Plan and Restatement of Prior Period Financial Statements

BayFirst Financial Corp. (NASDAQ: BAFN) ("BayFirst" or "Company"), parent company of BayFirst National Bank ("Bank") today announced that it has ...

Telix Pharmaceuticals Limited: First Patients Dosed in OPTIMAL-e Trial for Earlier Stage Prostate Cancer

First patients dosed in OPTIMAL-e1 Phase 2 study evaluating TLX597-Tx for metastatic hormone-sensitive prostate cancer at St Vincent's Hospital Sydney.OPTIMAL-e will evaluate TLX597-Tx in earlier pros ...

Webull Corporation Reports June 2026 Operating Data

Webull Corporation (NASDAQ: BULL) today reported select monthly operating data for June 2026. Registered Users ...

Mobia Medical, Inc.: Mobia Medical Appoints Reza Zadno, Ph.D., to its Board of Directors

Mobia Medical, Inc. (Nasdaq: MOBI), a commercial-stage medical device company redefining stroke recovery for survivors living with life-altering motor ...

Frequency Electronics, Inc. Announces Fourth Quarter and Fiscal Year 2026 Financial Results

Announces Record $111 Million Funded Backlog, up 34% Sequentially and 59% AnnuallyEstablishes Three-Year Minimum Gross Margin Target of 50% and Operating Margin Target of 30%Reaffirms Three-Year Reven ...

Celldex Therapeutics, Inc.: Celldex Announces Planned Transition of Chief Financial Officer

Celldex (NASDAQ:CLDX) announced today that Sam Martin, Senior Vice President and Chief Financial Officer, has informed the Company of his plans to retire ...